S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
Log in

Akebia Therapeutics SEC Filings & 10K Form (NASDAQ:AKBA)

$9.99
-0.16 (-1.58 %)
(As of 02/24/2020 04:00 PM ET)
Today's Range
$9.10
Now: $9.99
$10.15
50-Day Range
$6.61
MA: $8.18
$10.24
52-Week Range
$2.99
Now: $9.99
$10.53
Volume1.07 million shs
Average Volume1.43 million shs
Market Capitalization$1.19 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.71

SEC Filings

Akebia Therapeutics (NASDAQ:AKBA) SEC Filings

DateFilerForm TypeView
02/18/2020
6:00 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2020
12:05 PM
Akebia Therapeutics (Filer)
Form CT ORDER
11/22/2019
5:20 AM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:20 AM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:19 AM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
5:32 AM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
5:31 AM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
4:31 PM
Akebia Therapeutics (Filer)
Form 424B5
11/12/2019
4:20 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:31 PM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:59 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
11:52 AM
Akebia Therapeutics (Filer)
Form CT ORDER
09/11/2019
3:15 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
3:03 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:48 PM
Akebia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
7:22 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
3:04 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2019
3:10 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:04 PM
Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:03 PM
Akebia Therapeutics (Issuer)
Canute Scott A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:03 PM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
6:00 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:07 PM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:02 PM
Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2019
7:18 AM
Akebia Therapeutics (Filer)
Form DEFA14A
05/09/2019
7:16 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:05 PM
Akebia Therapeutics (Filer)
Form DEF 14A
04/18/2019
6:50 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
3:01 PM
Akebia Therapeutics (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:01 PM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:00 PM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:00 PM
Akebia Therapeutics (Issuer)
Tubridy Karen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:00 PM
Akebia Therapeutics (Issuer)
Amello Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
6:35 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
3:07 PM
Akebia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2019
5:02 AM
Akebia Therapeutics (Filer)
Form NT 10-K
03/18/2019
3:05 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2019
3:05 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:30 PM
ABRAMS CAPITAL MANAGEMENT, L.P. (Filed by)
Akebia Therapeutics (Subject)
Form SC 13G/A
01/25/2019
3:13 PM
Akebia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/11/2019
4:05 PM
Akebia Therapeutics (Subject)
Satter Muneer A (Filed by)
Form SC 13D/A
01/10/2019
4:05 PM
Akebia Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/09/2019
3:22 PM
Akebia Therapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
Form SC 13G
01/07/2019
2:05 PM
Akebia Therapeutics (Subject)
Novo Holdings A/S (Filed by)
Form SC 13G/A
01/07/2019
6:53 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2018
3:34 PM
Akebia Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13D/A
12/20/2018
5:06 AM
Akebia Therapeutics (Filer)
Form 8-K/A
12/13/2018
5:44 PM
Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
5:44 PM
Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
5:40 PM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
5:39 PM
Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
5:39 PM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
5:38 PM
Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
5:32 PM
Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2018
5:31 PM
Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2018
5:30 PM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2018
5:28 PM
Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2018
5:27 PM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2018
5:26 PM
Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2018
8:19 AM
Akebia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/13/2018
7:18 AM
Akebia Therapeutics (Issuer)
Tubridy Karen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
7:17 AM
Akebia Therapeutics (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
7:15 AM
Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
7:14 AM
Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
7:10 AM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
7:08 AM
Akebia Therapeutics (Issuer)
Amello Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
6:16 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2018
4:22 PM
ABRAMS CAPITAL MANAGEMENT, L.P. (Filed by)
Akebia Therapeutics (Subject)
Form SC 13G
11/30/2018
8:00 AM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
11/29/2018
6:03 AM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
11/16/2018
5:10 AM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
11/16/2018
5:10 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
5:08 AM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
11/15/2018
4:18 PM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
11/13/2018
3:06 PM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
11/13/2018
3:06 PM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
11/08/2018
3:35 PM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2018
11:15 PM
Akebia Therapeutics (Filer)
Form EFFECT
10/30/2018
4:29 PM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
10/30/2018
4:23 PM
Akebia Therapeutics (Filer)
Form 424B3
10/29/2018
4:27 PM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
10/29/2018
7:09 AM
Akebia Therapeutics (Filer)
Form S-4/A
10/25/2018
4:18 PM
Akebia Therapeutics (Filer)
Form S-4/A
10/02/2018
7:00 AM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
09/30/2018
11:00 PM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
09/30/2018
11:00 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2018
11:00 PM
Akebia Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
09/26/2018
3:03 PM
Akebia Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13D
09/14/2018
6:30 AM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
09/06/2018
7:31 AM
Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
Form 425
08/31/2018
11:02 AM
Akebia Therapeutics (Subject)
EAGLE ASSET MANAGEMENT INC (Filed by)
Form SC 13G/A
08/29/2018
3:02 PM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2018
3:01 PM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel